Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SAR 83.65
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very favourable analyst view
Data is available to registered users only
Data is available to registered users only
About
Ame Company For Medical Supplies distributes and markets medical supplies for the aesthetic market in Saudi Arabia. Its products portfolio includes Teoxane, a range of injectable hyaluronic acid-based dermal fillers designed to treat wrinkles on the face and neck; medical laser systems and new therapies; botulinum products; Magellan, an autologous concentration system that delivers concentrated...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is underpriced on P/E, of fair value on E
Data is available to registered users only
Target Price
Buy
Sell